Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)

5.89
Delayed Data
As of Dec 13
 +0.08 / +1.38%
Today’s Change
3.57
Today|||52-Week Range
9.93
+46.15%
Year-to-Date
No recent news for Tetraphase Pharmaceuticals Inc.

Today’s Trading

Previous close5.81
Today’s open5.80
Day’s range5.80 - 6.00
Volume1,713,745
Average volume (3 months)661,109
Market cap$298.7M
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)+10.59%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-55.97%
P/E ratioNM
Price/Sales28.75
Price/Book1.53

Competitors

 Today’s
change
Today’s
% change
IOVAIovance Biotherapeut...-0.20-2.25%
CNCEConcert Pharmaceutic...+0.58+2.23%
AVDLAvadel Pharmaceutica...-0.12-1.35%
TLGTTeligent Inc-0.05-1.27%
Data as of 4:00pm ET, 12/13/2017

Financials

Next reporting dateMarch 8, 2018
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$5.1M
Annual profit (last year)-$77.5M
Net profit margin-1,505.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Guy MacDonald
Chief Financial Officer
Kamalam Unninayar
Corporate headquarters
Watertown, Massachusetts

Forecasts